This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
To the Editor:—
The communication from our Canadian colleague Dolman in The Journal, May 19, criticizing the report of Kindel and Costello on their observations of the effect of staphylococcus toxoid on pustular dermatoses is evidently based on a misunderstanding. He fails to appreciate the background for the study and report of Kindel and Costello.Clinical departments in teaching institutions of medicine in the United States, as elsewhere, are continually being importuned by pharmaceutical manufacturers to try this or that product recommended in various clinical conditions. The reason for this is self evident.In Dr. Howard Fox's department of dermatology in the New York University and Bellevue Hospital Medical School it has always been the policy to give drug manufacturers a respectful hearing and, when the representation warranted, to assign interested members of the staff to make short but properly controlled clinical studies to secure first hand knowledge in respect
Sharlit H. STAPHYLOCOCCUS TOXOID IN PUSTULAR DERMATOSES. JAMA. 1934;103(2):125-126. doi:10.1001/jama.1934.02750280045024